Moderna, Pfizer and COVID-19

Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of infringing were invalid.
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in | Moderna sued Pfizer and BioNTech over three patents protecting its COVID-19 work back in 2022.
Moderna COVID Vaccine Technology Struck Down by PTAB
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s patents for its COVID-19 vaccine technology. The final written decisions remain sealed.
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In a statement, the court in the city of Duesseldorf said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation,
Pfizer and BioNTech COVID vaccine broke patent: German court
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine.
Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules
The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation
Moderna wins patent lawsuit against BioNTech/Pfizer in German court
A German court ruled on Wednesday that BioNTech and Pfizer violated a Covid-19 patent held by rival Moderna. US-based Moderna had asserted claims for information and damages for infringement of its patent rights in the development of the Covid-19 vaccine.
CNET on MSN18h
How the 3 New COVID Vaccines Change the Way You Pay
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...
Iowa bill asks vaccine manufacturers to waive indemnity against injury lawsuits
The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
Megyn Kelly claims Pfizer COVID vaccine left her with autoimmune condition: ‘Wish I hadn’t done it’
I asked the rheumatologist if it could be linked to the Pfizer vaccine and booster, and she said, ‘Yes, and you’re not the only patient I have who’s had this sequence of ...
STAT10d
A small study on Covid vaccine safety sparks an online tempest
A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.
5 years on: What's the real truth about Covid-19?
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
Rolling Out11d
What to know about the latest vaccine updates
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
Bellingham employees appeal judge dismissal over COVID-19 vaccine firings
Eighteen former city employees have taken their case to federal court after suing Bellingham for being terminated over ...
McKnight's Long-Term Care News1d
Report: COVID-19 vaccine 33 percent effective at thwarting emergency, urgent care visits
The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...